A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2002
11/28/2002	US20020177547 Nucleic acid molecule encoding a tumor-associated antigen and a peptide comprising a region corresponding to a putative cytotoxic T cell, helper T cell or B cell epitope of the antigen and/or cells pulsed with such peptidse
11/28/2002	US20020177213 Tissue plasminogen activator-like protease
11/28/2002	US20020177209 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
11/28/2002	US20020177200 Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
11/28/2002	US20020177145 Detection and classification of nervous system progenitor cells; obtain tissue, monitor expression of daedalos protein in sample, compare to control, ampified daedalos expression indicates presence of nervous system progenitor cells
11/28/2002	US20020177128 Variant of LAV viruses
11/28/2002	US20020176904 Antiprotozal composition
11/28/2002	US20020176871 A nucleic acids encoding an intracellular mature virion antigen and at least one nucleic acid encoding an extracellular enveloped virion antigen of a poxvirus
11/28/2002	US20020176869 Hepatitus A virus vaccines
11/28/2002	US20020176868 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
11/28/2002	US20020176867 Fusion proteins of the immunodominant antigens ESAT-6 and Ag85B from Mycobacterium tuberculosis or homologues, and the vaccine based on fusion protein, which induces efficient immunological memory
11/28/2002	US20020176863 A carrier fused to an amino-terminal peptide fragment of streptococcal M protein having an epitope that elicits opsonic antibodies to group A streptococci serotype without eliciting crossreactive antiboides to mammalian tissue antigens
11/28/2002	US20020176862 A protein (Sm 16.8) with anti-inflammatory, and immunomodulatory functions was identified and isolated from the excretory/secretions of a human parasite, Schistosoma manson
11/28/2002	US20020176861 A phosphate derivative when co-administered with antigens such as vaccines for bacterial and viral diseases function as immunological adjuvant
11/28/2002	US20020176856 Administering an antibody to the mammal, that binds with a specified target epitope of an antigen, associated with a tumor or an infectious agent; having engineered glycosylation site in the constant region of the heavy chain antibodies
11/28/2002	US20020176855 Humanized immunoglobulin reactive with b7-2 and methods of treatment therewith
11/28/2002	US20020176850 Immunotherapy of cancer with allogeneic lymphocytes
11/28/2002	US20020176845 Injectable tumor vaccines comprising an antigenic cellular material and an immunostimulant adsorbed to adjuvants material; stimulating immune responses to specific tumor antigens
11/28/2002	DE10123505A1 New immunoconjugate comprising egg yolk immunoglobulin Y, useful for treating e.g. inflammation or infection, is derived from specific pathogen-free hens
11/28/2002	CA2755964A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	CA2448031A1 Method for stabilising of nucleic acids
11/28/2002	CA2448022A1 Compositions for protein delivery via the pulmonary route
11/28/2002	CA2448018A1 Compositions and methods for inhibiting metastasis
11/28/2002	CA2447958A1 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002	CA2447795A1 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
11/28/2002	CA2447793A1 Immunostimulatory oligodeoxynucleic molecules
11/28/2002	CA2447680A1 Hevein-binding monoclonal antibodies
11/28/2002	CA2447616A1 Vaccine composition
11/28/2002	CA2447599A1 Peptide vaccines against group a streptococci
11/28/2002	CA2447340A1 Kinases and phosphatases
11/28/2002	CA2447313A1 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	CA2447274A1 Heterologous protection induced by immunization with invaplex vaccine
11/28/2002	CA2447215A1 Adherent entities and uses therefor
11/28/2002	CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002	CA2444487A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists
11/28/2002	CA2443438A1 Cytotoxic cd44 antibody immunoconjugates
11/28/2002	CA2443437A1 Antibodies specific for cd44v6
11/28/2002	CA2443258A1 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
11/28/2002	CA2440368A1 Staphylococcus aureus proteins and nucleic acids
11/28/2002	CA2433644A1 Myostatin immunoconjugate and its use for immunisation
11/27/2002	EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002	EP1260581A1 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
11/27/2002	EP1260521A2 Immunoglobulin variants for specific Fc epsilon receptors
11/27/2002	EP1260213A2 Form of administration of immunologically active ingredients
11/27/2002	EP1259814A1 Bcmp-7 as marker for diagnosis of breast cancer
11/27/2002	EP1259813A2 Diagnosis and treatment of malignant neoplasms
11/27/2002	EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002	EP1259648A2 Diagnostics and therapeutics for glaucoma
11/27/2002	EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
11/27/2002	EP1259639A2 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
11/27/2002	EP1259629A2 Recombinant influenza a viruses
11/27/2002	EP1259615A1 Human antibodies against eotaxin and their use
11/27/2002	EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002	EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002	EP1259604A1 Bcmp 84, a protein associated to breast cancer
11/27/2002	EP1259592A1 Monocyte-derived dendritic cell subsets
11/27/2002	EP1259591A2 Polypetptides and methods for thymic vaccination
11/27/2002	EP1259548A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
11/27/2002	EP1259547A2 High potency recombinant antibodies and method for producing them
11/27/2002	EP1259545A2 Small cell lung cancer associated antigens and uses therefor
11/27/2002	EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002	EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002	EP1259265A2 Nucleic acid formulations for gene delivery and methods of use
11/27/2002	EP1259259A2 Mucosal adjuvant formulation
11/27/2002	EP1259258A1 Gm-negative ehv-mutants
11/27/2002	EP1259257A2 In ovo protection against infectious bronchitis
11/27/2002	EP1259251A2 Novel method for down-regulation of amyloid
11/27/2002	EP1259248A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d
11/27/2002	EP1259246A2 Use of dpp-iv inhibitors for the treatment of diabetes
11/27/2002	EP0994887B1 Modified glycosides, compositions comprised thereof and methods of use thereof
11/27/2002	EP0700402B1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
11/27/2002	EP0675961B1 Treatment of tumorigenic disease with a modified HSV
11/27/2002	EP0671928B1 Synthesis of n-substituted oligomers
11/27/2002	EP0630409B1 Defective packaging non-oncoviral vectors based on mpmv
11/27/2002	EP0627933B1 Bystander suppression of autoimmune diseases
11/27/2002	EP0608261B1 Immunoreactive hepatitis c virus polypeptide compositions
11/27/2002	EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002	CN1382216A DNA coding for beta-tubulin and use thereof
11/27/2002	CN1382158A Multiple cytokine-antibody complexes
11/27/2002	CN1382153A 重组亚单位疫苗 Recombinant subunit vaccine
11/27/2002	CN1382060A Dosages for treatment with anti-ErbB2 antibodies
11/27/2002	CN1382059A Method and compositions for prevneting or reducing HIV infection
11/27/2002	CN1381582A Targetting high-expression recombinant adenovirus of human granulocyte-macrophage colony stimulating factor and its preparing process and usage
11/27/2002	CN1381563A Recombinant adenovirus expressing human rotavirus VP7 and its preparing process and usage
11/27/2002	CN1381562A Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage
11/27/2002	CN1381461A Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application
11/27/2002	CN1094974C Recombined adhenovirus expressing human interleukin 12 and its preparation and use
11/27/2002	CN1094973C Recombined adhenovirus expressing human interleukin 18 and its preparation and use
11/26/2002	US6486311 Peanut allergens and methods
11/26/2002	US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
11/26/2002	US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/26/2002	US6486209 Use for 1,3-propanediol derivatives
11/26/2002	US6486135 Nucleic acid respiratory syncytial virus vaccines
11/26/2002	US6486130 Immunogenic formulation of OSPC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
11/26/2002	US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins
11/26/2002	US6485960 Polycystic kidney disease 1 gene and uses thereof
11/26/2002	US6485940 Broad spectrum infectious bursal disease virus vaccine
11/26/2002	US6485932 Composition comprising immunoglobulin
11/26/2002	US6485929 Method for inhibiting CD95-independent apoptosis in AIDS
11/26/2002	US6485919 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof

1 ... 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 ... 1823